News-Medical.Net on MSN
Insulin anxiety and workplace barriers complicate gestational diabetes care
Insulin use in gestational diabetes presents challenges; education and support are key to overcoming fears and ensuring ...
The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.
Recent Returns Put Long Term Performance in Context Novo Nordisk (NVO) has drawn attention after recent share price moves, ...
Dr Rachel Smith has become the first woman in the world with type 1 diabetes to reach the highest point in the world’s ...
Switzerland-based Sandoz, a global leader in affordable medicines, today confirmed that the European Commission has granted ...
Explore the complexities of insulin biosimilars, their safety, and the impact on diabetes management in global health systems ...
In the episode titled ‘The Trouble With Sarah’ of NBC’s ‘Dateline,’ the primary focus is on the mysterious death of Joseph ...
Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
Everyday Health on MSN
The pros, cons, and considerations of taking Ozempic or other drugs for weight loss
Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and potential side effects.
A fascinating deep dive into the discovery, use and implications of a revolutionary new treatment ...
Everyday Health on MSN
Zepbound vs. Wegovy: Which obesity treatment might be right for you?
Wegovy and Zepbound are two FDA-approved weight loss drugs. Learn how they compare in benefits, side effects, and more to ...
The Trump-Vance administration took office on Jan. 20, 2025. The White House proceeded to dismantle the U.S. Agency for International Development, which funded LGBTQ and intersex rights organizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results